Plasma free captopril concentrations and haemodynamic response to captopril were studied
in 20 patients with severe chronic heart failure. A 25 mg oral dose of captopril produced a …

The effect of intravenous captopril was studied in 26 patients with severe chronic heart
failure. Fourteen patients received a 25 mg intravenous bolus dose and 12 patients were …

We investigated the kinetics of 25 mg Captopril by mouth in 12 patients with congestive
heart failure and correlated them with the hormonal and hemodynamic changes associated …

The hemodynamic effects of captopril (SQ 14225), an oral inhibitor of angiotensin-converting
enzyme, were measured in 10 patients with severe chronic heart failure poorly controlled by …

To determine the relationship between the early and late hemodynamic effects of captopril in
patients with severe heart failure, we performed serial right heart catheterizations in 51 such …

1 The clinical and haemodynamic effects of low doses of the oral converting‐enzyme
inhibitor captopril were studied in 18 patients with severe chronic heart failure. Increasing …

The angiotensin-converting enzyme inhibitor, captopril, was given to 19 patients with severe
heart failure. Seven patients had acute myocardial infarction and the remainder had chronic …

The hemodynamic and hormonal responses to acute and chronic captopril therapy and to its
temporary withdrawal were studied in seven patients with congestive heart failure. Maximal …

A study was made of ten subjects with post myocardial left ventricular failure. All patients
were treated with captopril with successive doses of 12.5 mg, 25 mg, 50 mg. Heart rate and …

Hemodynamic and neurohumoral effects of intravenous captopril were studied in ten
patients with severe chronic congestive heart failure (NYHA Functional Class III and IV) …